Fifty-three bladder biopsies with previous diagnosis of benign/reactive, dysplastic, carcinoma in situ or carcinoma were prepared using a tripleimmunostain cocktail consisting of CK20, P53 and CD44. This evidence concerns the gene TP53 and carcinoma.